Literature DB >> 4145923

Alternative potentiating and inhibitory effects of GVH reaction on formation of antibodies against a thymus-independent polysaccharide (S3).

P Byfield, G H Christie, J G Howard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4145923

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.

Authors:  F L Shand
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

2.  Analysis of immunosuppression generated by the graft-versus-host reaction. II. Characterization of the suppression cell and its mechanism of action.

Authors:  F L Shand
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

3.  Biological effects of Escherichia coli lipopolysaccharide (LPS) in vivo. I. Selection in the mouse thymus of killer and helper cells.

Authors:  C D Baroni; G S De Franceschi; S Uccini; L Adorini; G D Cnen; L Ruco
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

4.  The immune reponse to type III pneumococcal polysaccharide in mice with malaria.

Authors:  N Wedderburn; B N Dracott
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

5.  Immunosuppression in murine malaria. I. Response to type III pneumococcal polysaccharide.

Authors:  J S McBride; H S Micklem; J M Ure
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

6.  The requirement for C3 receptors on the precursors of 19S and 7S antibody-forming cells.

Authors:  D W Mason
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

7.  Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III.

Authors:  V J Pasanen; R Asofsky; P J Baker
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.